Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial
Keywords:
Cholinergic urticaria
Omalizumab
Clinical trial
Exercise
Exercise challenge test
Cholinergic urticaria
UCOL score
Citation:
Gastaminza, G. (Gabriel); Azofra, J. (Julián); Nuñez-Cordoba, J.M. (Jorge M.); et al. "Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial". The Journal of Allergy and Clinical Immunology: In Practice. 7 (5), 2019, 1599 - 1609
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.